Fetal Monitoring Market (By Product: Ultrasound, Electronic Fetal Monitoring (EFM); By Method: Invasive, Non-invasive, By Portability: Portable, Non-portable; By Application: Intrapartum fetal monitoring, Antepartum fetal monitoring; By End user: Others, Hospitals and maternity hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Fetal Monitoring Market
5.1. COVID-19 Landscape: Fetal Monitoring Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Fetal Monitoring Market, By Product
8.1. Fetal Monitoring Market Revenue and Volume, by Product, 2024-2034
8.1.1. Ultrasound
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Electronic Fetal Monitoring (EFM)
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Fetal Monitoring Market, By Method
9.1. Fetal Monitoring Market Revenue and Volume, by Method, 2024-2034
9.1.1. Invasive
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Non-invasive
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Fetal Monitoring Market, By Portability
10.1. Fetal Monitoring Market Revenue and Volume, by Portability, 2024-2034
10.1.1. Portable
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Non-portable
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Fetal Monitoring Market, By Application
11.1. Fetal Monitoring Market Revenue and Volume, by Application, 2024-2034
11.1.1. Intrapartum fetal monitoring
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Antepartum fetal monitoring
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 12. Global Fetal Monitoring Market, By Application
12.1. Fetal Monitoring Market Revenue and Volume, by Application, 2024-2034
12.1.1. Others
12.1.1.1. Market Revenue and Volume Forecast (2021-2034)
12.1.2. Hospitals and maternity hospitals
12.1.2.1. Market Revenue and Volume Forecast (2021-2034)
12.1.3. Clinics
12.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 13. Global Fetal Monitoring Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.1.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.1.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.6.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.1.7.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.1.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.1.7.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.2.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.2.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.2.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.2.7. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.8. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.2.9.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.2.10. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.11. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.2.12.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.2.12.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.13. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.2.14.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.2.14.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.2.15. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.3.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.3.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.7. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.3.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.9. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.3.10.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.3.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.10.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.3.11.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.3.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.3.11.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.4.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.4.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.7. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.4.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.9. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.4.10.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.4.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.10.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.4.11.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.4.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.4.11.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.5.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.5. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.5.6.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.7. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Volume Forecast, by Method (2021-2034)
13.5.8.3. Market Revenue and Volume Forecast, by Portability (2021-2034)
13.5.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
13.5.8.5. Market Revenue and Volume Forecast, by Application (2021-2034)
Chapter 14. Company Profiles
14.1. GE Healthcare
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Siemens Healthineers
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Koninklijke Philips N.V.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. FUJIFILM SonoSite, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cardinal Health, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Nemo Healthcare
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Mindchild Medical Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Edan Instrument Inc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Clinical Innovation, LLC
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Neoventa Medical AB
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client